Interestingly, in a study by Moisa et al., it was observed that JAK2-V617F-positive ET patients with previous thrombosis had higher oxidative stress levels than patients without any previous occurrence of thrombotic events [80]. This evidence concerns the gene JAK2 and Venous thrombosis.